Alzheimer's disease

Thumped by the FDA, Accera’s attempt to do a serious Alzheimer’s PhIII ends with a flop
Endpoints
Tue, 02/28/17 - 11:14 am
FDA
Accera
Alzheimer's disease
clinical trials
Axona
medical food
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Tue, 02/28/17 - 10:05 am
Roche
AC Immune
Alzheimer's disease
clinical trials
crenezumab
Merck stopping late stage study as another Alzheimer's drug fails
Yahoo/Reuters
Tue, 02/14/17 - 07:43 pm
Merck
Alzheimer's disease
verubecestat
clinical trials
Lundbeck reads last rites on another failed PhIII Alzheimer’s program
Endpoints
Wed, 02/8/17 - 09:26 am
Lundbeck
Otsuka
Alzheimer's disease
idalopirdine
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Xtalks
Fri, 01/27/17 - 09:30 am
AbbVie
clinical trials
anti-tau antibodies
Alzheimer's disease
ABBV-8E12
Five 'Big Idea' Biotech Trends to Watch in 2017
Forbes
Wed, 12/28/16 - 09:49 am
biotech
protein targets
Alzheimer's disease
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Tue, 12/20/16 - 12:29 pm
Acadia
Alzheimer's disease
pimavanserin
Over And Out For Solanezumab, While Biogen Takes The Spotlight
Seeking Alpha
Tue, 12/13/16 - 10:22 am
solanezumab
Biogen
Eli Lilly
aducanumab
Alzheimer's disease
Why the latest Alzheimer’s data is (mostly) great news for Biogen
Bizjournals.com
Sun, 12/11/16 - 11:52 am
Alzheimer's disease
Biogen
aducanumab
PFE Bounces, But Is It Just A Dead Cat?
Investopedia
Sat, 12/10/16 - 10:31 am
Pfizer
Akili Interactive
Alzheimer's disease
Eli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment
Marketwatch
Fri, 12/9/16 - 09:49 am
Eli Lilly
AstraZeneca
Alzheimer's disease
Eli Lilly conducts an autopsy of an Alzheimer’s megaflop
Endpoints
Thu, 12/8/16 - 11:12 pm
Eli Lilly
Alzheimer's disease
solanezumab
Can Biogen solve the Alzheimer’s drug riddle? We could find out within days
Bizjournals.com
Thu, 12/8/16 - 09:55 am
Biogen
Alzheimer's disease
aducanumab
clinical trials
Why Eli Lilly Shares Lost 8% in November
Motley Fool
Sun, 12/4/16 - 12:23 pm
Eli Lilly
clinical trials
solanezumab
Alzheimer's disease
In Lechleiter’s final days, Eli Lilly flags upcoming job cuts in the wake of a PhIII implosion
Endpoints
Wed, 11/30/16 - 10:10 am
Eli Lilly
John Lechleiter
layoffs
solanezumab
Alzheimer's disease
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
TheStreet.com
Tue, 11/29/16 - 09:49 am
Eli Lilly
Alzheimer's disease
solanezumab
AC Immune
Axovant
Biogen
Merck
Roche
Does Lilly's Alzheimer's Fail Hurt Biogen?
Investopedia
Fri, 11/25/16 - 09:22 am
Biogen
Eli Lilly
Alzheimer's disease
solanezumab
Lilly's sola failure throws Alzheimer's theory into doubt
BioPharma Dive
Fri, 11/25/16 - 09:21 am
Eli Lilly
solanezumab
Alzheimer's disease
Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news
Bizjournals.com
Wed, 11/23/16 - 12:05 pm
Biogen
Eli Lilly
Alzheimer's disease
solanezumab
Eli Lilly (LLY) CEO Lechleiter 'Disappointed,' after Alzheimer's Drug Fails
TheStreet.com
Wed, 11/23/16 - 10:29 am
Eli Lilly
Alzheimer's disease
clinical trials
solanezumab
John Lechleiter

Pages